Jeffrey S Mathiesen Receives Stock Award at Neuroone Medical Technologies Corp (NMTC) — SEC Form 4, Jun 25, 2025
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Jeffrey S Mathiesen CIK 0001296853 |
Director
|
Jeffrey S Mathiesen at Neuroone Medical Technologies Corp
Full insider history
Bought (12 mo)
—
Sold (12 mo)
—
More from this insider at Neuroone Medical Technologies Corp
| 2026-04-07 | Award | — | View |
| 2025-02-19 | Award | — | View |
| 2023-03-20 | Award | — | View |
| 2022-06-02 | Award | — | View |
| 2021-06-04 | Award | — | View |
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $0.66 | 2025-06-23 | A - Award/Grant | 50,000 A | $0.00 | 2035-06-23 | 50,000 Common Stock | Direct |
Footnotes (1)
- F1
- The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month. Show more
Related filings at Neuroone Medical Technologies Corp
Institutional Holders
13F holders · Jun 30, 2026
2
institutional managers reporting a position
Largest by reported value
5%+ Holders · 13D/G
3 filers
-
Brian Pratt 12.5%
-
Bleichroeder Lp 8.0%
Other insiders at Neuroone Medical Technologies Corp
GET /v1/forms/4/0001656026-25-000004
API docs
View Original SEC Filing